<PAGE> 1
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------------
SCHEDULE 14D-9
SOLICITATION/RECOMMENDATION STATEMENT
PURSUANT TO SECTION 14(D)(4) OF THE
SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1)
------------------------------
DEKALB GENETICS CORPORATION
(Name of Subject Company)
DEKALB GENETICS CORPORATION
(Name of Person(s) Filing Statement)
CLASS B COMMON STOCK, WITHOUT PAR VALUE
(Title of Class of Securities)
244878 20 3
(CUSIP Number of Class of Securities)
John H. Witmer, Jr., Esq.
Senior Vice President and General Counsel
3100 Sycamore Road
DeKalb, Illinois 60115
(815) 758-3461
(Name, address and telephone number of person
authorized to receive notice and communications
on behalf of the person(s) filing statement)
------------------------------
COPIES TO:
<TABLE>
<S> <C>
James G. Archer Peter D. Lyons
Sidley & Austin Shearman & Sterling
875 Third Avenue 599 Lexington Avenue
New York, NY 10022 New York, NY 10022
(212) 906-2000 (212) 848-4000
</TABLE>
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE> 2
ITEM 1. SECURITY AND SUBJECT COMPANY.
This Amendment No. 1 amends and supplements the Solicitation/Recommendation
Statement on Schedule 14D-9 filed with the Securities and Exchange Commission on
February 7, 1996 (as amended, the "Schedule 14D-9") by DEKALB Genetics
Corporation, a Delaware corporation (the "Company"), relating to the tender
offer by Monsanto Corporation, a Delaware corporation ("Monsanto"), to purchase
up to 1,800,000 shares of the Company's Class B Common Stock, without par value,
at a price per share of $71.00 net to the seller in cash, upon the terms and
subject to the conditions set forth in the Offer to Purchase of Monsanto dated
February 7, 1996 and in the related Letter of Transmittal.
ITEM 8. ADDITIONAL INFORMATION TO BE FURNISHED.
Item 8 of the Schedule 14D-9 is hereby amended and supplemented as follows:
On February 9, 1996, the Company issued a press release. A copy of such
press release is filed hereto as Exhibit 12, and is incorporated herein by
reference.
ITEM 9. MATERIAL TO BE FILED AS EXHIBITS.
Exhibit 12 Press Release of the Company dated February 9, 1996.
1
<PAGE> 3
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
By: THOMAS R. RAUMAN
------------------------------------
Name: Thomas R. Rauman
Title: Chief Financial Officer
Dated: February 9, 1996
2
<PAGE> 4
EXHIBIT INDEX
<TABLE>
<S> <C>
Exhibit 12 Press Release of the Company dated February 9, 1996
</TABLE>
3
<PAGE> 1
[DEKALB GENETICS CORPORATION LOGO]
NEWS RELEASE
Thomas R. Rauman
Chief Financial Officer
(815) 758-9223
FOR IMMEDIATE RELEASE
FRIDAY, FEBRUARY 9, 1996
DEKALB GENETICS DECLARES REGULAR QUARTERLY CASH DIVIDEND
DEKALB, Illinois, February 9, 1996 -- DEKALB Genetics Corporation today
announced that its board of directors has declared a regular quarterly cash
dividend of 20 cents per share on Class A and Class B Common Stock.
The dividend is payable March 8, 1996 to shareholders of record February
23, 1996.
Based in DeKalb, Illinois, DEKALB Genetics Corporation is engaged in the
research, production and marketing of agricultural seed and swine breeding
stock. DEKALB Genetics Corporation Class B Common Stock is traded on the NASDAQ
National Market System, under the symbol SEEDB.
###
3100 SYCAMORE ROAD, DEKALB, IL 60115-9600
815/758-3461 FAX: 815/758-3711
4.1
